Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/30/2025

Autoimmune Gastritis Diagnosis and Management

Introduction to Autoimmune Gastritis

  • The American Gastroenterological Association recommends identifying high-risk populations, including patients with unexplained iron deficiency anemia, vitamin B12 deficiency, and other autoimmune disorders, for autoimmune gastritis diagnosis 1

Diagnostic Criteria

  • The diagnosis of autoimmune gastritis is characterized by corpus-predominant atrophic gastritis, loss of oxyntic glands with lymphoplasmacytic infiltrate, pseudopyloric metaplasia and/or intestinal metaplasia, and relative sparing of the antrum, as noted by the American Gastroenterological Association 1
  • Endoscopic features of autoimmune gastritis include a pale appearance of gastric mucosa, increased visibility of submucosal vessels, loss of gastric rugal folds, and corpus-predominant pattern with antral sparing, according to the American Gastroenterological Association 1
  • The American Gastroenterological Association suggests that biopsy protocol should include obtaining biopsies from both corpus and antrum in separate containers, targeting any visible atrophic/metaplastic areas, and including additional samples from any mucosal abnormalities 1
  • Histological findings include oxyntic mucosa atrophy with lymphoplasmacytic infiltrate, loss of gastric glands in corpus/fundus, and intestinal metaplasia (often present) 1
  • The presence of positive parietal cell antibodies (PCA) with negative endoscopic biopsies suggests early autoimmune gastritis, and testing for intrinsic factor antibodies (IFA) can increase diagnostic sensitivity to 86.36% 1

Screening and Surveillance

  • The American Gastroenterological Association recommends endoscopic surveillance every 3 years for advanced atrophic gastritis, with individualized intervals based on risk assessment 1
  • The European Society of Gastrointestinal Endoscopy suggests considering endoscopic surveillance every 3 years based on risk assessment, with more frequent surveillance warranted if additional risk factors develop, such as vitamin B12 deficiency or iron deficiency anemia 2, 1
  • Annual assessment of vitamin B12 and iron status, complete blood count, and periodic gastrin level measurement are recommended by the American Gastroenterological Association for laboratory monitoring 1
  • Regular evaluation for type 1 gastric neuroendocrine tumors, with endoscopic surveillance every 1-2 years if tumors are detected, is suggested by the American Gastroenterological Association 1
  • Manage NETs by removing small tumors endoscopically and conducting follow-up surveillance every 1-2 years depending on tumor burden 1, 3

Associated Conditions and Complications

  • Up to 94% of patients with autoimmune gastritis have other autoimmune disorders, particularly autoimmune thyroid disease, as noted by the American Gastroenterological Association 1
  • The American Gastroenterological Association recommends always evaluating for vitamin B12 and iron deficiencies, as these may be the first manifestations of disease 1
  • Misdiagnosis as H. pylori gastritis can occur, but autoimmune gastritis typically shows corpus-predominant atrophy with antral sparing, according to the American Gastroenterological Association 1
  • The American Gastroenterological Association recommends testing for H. pylori using non-serological methods (urea breath test or stool antigen), and if positive, treating and confirming eradication 1, 3
  • Screening for associated autoimmune conditions, such as autoimmune thyroid disease, type 1 diabetes, vitiligo, and celiac disease, is recommended, as up to 94% of patients with autoimmune gastritis have other autoimmune disorders 1
  • Hematologic manifestations may include unexplained iron deficiency anemia, vitamin B12 deficiency/pernicious anemia, and macrocytic anemia 1

Management and Treatment

  • Annual monitoring of vitamin B12 and iron status is recommended, as well as monitoring complete blood count for development of anemia, to prevent complications related to micronutrient deficiencies 1
  • The American College of Gastroenterology recommends supplementing vitamin B12 if deficient, with oral supplementation for early disease and parenteral administration if pernicious anemia develops, and iron supplementation if deficient 1
  • Periodic gastrin level measurement may be considered, as elevated levels can indicate advanced disease 1
  • Evaluate vitamin B12 levels through serum B12, methylmalonic acid, and homocysteine tests, and assess iron status through complete blood count, serum iron, ferritin, and transferrin saturation 1
  • Replace micronutrients through vitamin B12 supplementation (parenteral if pernicious anemia present) and iron supplementation if deficient 1

Follow-up and Prevention

  • Regular follow-up is necessary, as autoimmune gastritis is a progressive condition requiring ongoing monitoring to prevent complications related to micronutrient deficiencies and disease progression 1
  • Common pitfalls include failure to recognize atrophic gastritis, inadequate biopsy sampling, overlooking micronutrient deficiencies, missing associated autoimmune conditions, and inadequate H. pylori testing 1, 3